Global Negative Pressure Wound Therapy (NPWT) Devices Market: Key Developments
On October 13, 2022, 3M Health Care Medical Solutions, a division of 3M, announced that its 3M V.A.C. Therapy negative pressure wound therapy (NPWT) had surpassed a clinical evidence milestone of 2,000 published, peer-reviewed medical journal studies. V.A.C. Therapy is the first and only NPWT solution to garner this number of published studies about its therapy. It is backed by more clinical data than any other brand, accounting for more than 75% of published NPWT clinical evidence.
On August 24, 2021, Aatru Medical, LLC, a privately-held medical device company, announced that it had received the U.S. Food and Drug Administration (FDA) 510(k) Class II clearance for its NPSIMS Negative Pressure Surgical Incision Management System for the NPWT market.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients